Insider Restricted Stock Sale Filed for NXPI — 2,000 Shares via Morgan Stanley
Rhea-AI Filing Summary
Form 144 filed for NXP Semiconductors (NXPI) notifies a proposed sale of 2,000 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $439,149.00 and an approximate sale date of 08/12/2025 on NASDAQ. The filing reports 252,114,595 shares outstanding, placing the proposed sale at an immaterial fraction of total shares.
The securities listed were recently granted as restricted stock in November 2024: 1,033 shares acquired 11/01/2024, 504 shares acquired 11/02/2024, and 463 shares acquired 11/07/2024. The filer states there are no sales to report in the past three months and affirms no undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small planned sale of recently acquired restricted shares; transaction size is immaterial to market capitalization.
The Form 144 shows a proposed brokered sale of 2,000 common shares valued at $439,149, compared with 252,114,595 shares outstanding. That scale implies the filing is routine and unlikely to affect share liquidity or valuation materially. The shares were acquired as restricted stock across early November 2024 and are being sold through Morgan Stanley Smith Barney LLC with an August 12, 2025 sale date. No prior three-month sales are reported, and the filer affirms no undisclosed material adverse information.
TL;DR: Disclosure is standard for insider/affiliate selling; filings disclose acquisition dates and broker details without governance red flags.
The notice identifies the securities as restricted stock received in November 2024 and lists the executing broker and planned sale date. There is no indication of accelerated or large-scale disposition, no reported sales in the prior three months, and the filer makes the customary representation regarding material information. From a governance perspective, the filing aligns with routine reporting obligations and does not raise immediate compliance concerns based on the disclosed data.